M&A Deal Summary

Golden Gate Capital Acquires Antylia Scientific

On May 1, 2017, private equity firm Golden Gate Capital acquired life science company Antylia Scientific

Acquisition Highlights
  • This is Golden Gate Capital’s 2nd transaction in the Life Science sector.
  • This is Golden Gate Capital’s 3rd transaction in the United Kingdom.

M&A Deal Summary

Date 2017-05-01
Target Antylia Scientific
Sector Life Science
Buyer(s) Golden Gate Capital
Deal Type Buyout (LBO, MBO, MBI)

Target

Antylia Scientific

Saint Neots, United Kingdom
Antylia Scientific is a provider of peristaltic and single-use bioprocessing solutions as well as a diverse portfolio of life sciences and diagnostic products for the pharma, biopharma, healthcare and environmental markets. Our life sciences portfolio includes well-recognized brands such as the environmental sampling and testing innovator, Environmental Express®; real-time monitoring and cold storage expertise at Traceable®; our standards and external diagnostic control specialists, SPEX® and ZeptoMetrix®; and our lab essentials and consumables Cole-Parmer Essentials brand. Antylia Scientific is based in Saint Neots, United Kingdom.

Search 200,291 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Golden Gate Capital

San Francisco, California, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2000
PE ASSETS 19.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Golden Gate Capital is a large private equity firm focused on buyout and growth equity investments across a wide variety of industries. The Firm partners with management teams to make equity investments in situations where there is a demonstrable opportunity to significantly enhance a company's value. Sectors of interest include software and IT services, semiconductors, electronics, consumer products and retail, financial services, business services, and media. Prospective transaction types include public-to-privates, corporate extractions, bankruptcy auctions, and recapitalizations. Golden Gate Capital was formed in 2000 and is based in San Francisco, California.


DEAL STATS #
Overall 90 of 112
Sector (Life Science) 2 of 2
Type (Buyout (LBO, MBO, MBI)) 23 of 27
Country (United Kingdom) 3 of 3
Year (2017) 5 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-05-01 2020

Laval, Quebec, Canada

2020 is a provider of computer-aided design, business and manufacturing software tailored for the interior design and furniture industries. The company has developed an unmatched depth of knowledge of interior design and space planning to maintain an unbroken history of the market and thought leadership. Its customers include many of the world’s largest home improvement retailers and manufacturers, as well as tens of thousands of local, independent kitchen and bathroom dealers. 2020 was founded in 1987 and is based in Laval, Quebec.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-05-04 Vantage

Bronx, New York, United States

Vantage is a North American elevator component manufacturer, providing a broad portfolio of made-to-order parts that includes nearly every electromechanical component used in elevator systems: door operators and associated door equipment, geared and gearless traction machines, universally compatible microprocessor controllers, safety components, signal fixtures, push button panels, and structural assemblies. Vantage sells its products to independent elevator service companies and OEMs engaged in the installation, maintenance and modernization of elevators. Vantage was founded in 1927 and is based in Bronx, New York.

Buy -